Global Blood Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:N/A
Lead Investor(s):Cantor Fitzgerald & Co.

City Ranking

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Global Blood Therapeutics's estimated annual revenue is currently $24M per year.(?)
  • Global Blood Therapeutics received $115.0M in venture funding in December 2017.
  • Global Blood Therapeutics's estimated revenue per employee is $56,663

Employee Data

  • Global Blood Therapeutics has 424 Employees.(?)
  • Global Blood Therapeutics grew their employee count by 12% last year.
  • Global Blood Therapeutics currently has 28 job openings.

Global Blood Therapeutics (GBT) (NASDAQ: GBT), based in South SF, is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. We aim to make a significant impact by treating the root cause or making a meaningful difference in the standards of care. Through in-licensing and continued research and development, were committed to Hope+Science+Community. You can view our social community guidelines at